MedTrace Logo

A Randomized Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC

NCT04654520 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 290

Last updated 2020-12-04

No results posted yet for this study

Summary

The aim of this randomized study is to investigate local tumor control, survival outcomes,and complications on patients of stage Ⅳ non small-cell lung cancer ,whom based on medication with concurrent primary radiotherapy omitting clinical tumor volume.

Conditions

  • Radiotherapy
  • Nonsmall Cell Lung Cancer, Stage IV

Interventions

OTHER

Drug therapy concurrent radiotherapy for primary tumor omitted CTV

Thoracic intensity modulated radiotherapy for primary tumor omitted CTV+Chemotherapy or Targeted drug therapy

Sponsors & Collaborators

  • Guizhou Medical University

    lead OTHER

Principal Investigators

  • Bing Lu, Bachelor · Affiliated Hospital of Guizhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-15
Primary Completion
2021-12-31
Completion
2022-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04654520 on ClinicalTrials.gov